Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $5,038 | 4 | 32.4% |
| Food and Beverage | $4,622 | 224 | 29.7% |
| Consulting Fee | $3,570 | 2 | 23.0% |
| Travel and Lodging | $2,144 | 12 | 13.8% |
| Education | $177.98 | 9 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lundbeck LLC | $6,368 | 24 | $0 (2024) |
| UCB, Inc. | $5,572 | 36 | $0 (2024) |
| SK Life Science, Inc. | $1,000 | 37 | $0 (2024) |
| Avadel CNS Pharmaceuticals, LLC | $606.23 | 21 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $413.31 | 23 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $249.76 | 23 | $0 (2021) |
| Greenwich Biosciences, Inc. | $214.51 | 18 | $0 (2021) |
| ABBVIE INC. | $180.01 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $156.17 | 6 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $95.59 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,638 | 75 | UCB, Inc. ($5,284) |
| 2023 | $704.72 | 29 | SK Life Science, Inc. ($278.70) |
| 2022 | $591.16 | 48 | JAZZ PHARMACEUTICALS INC. ($133.89) |
| 2021 | $493.86 | 38 | Greenwich Biosciences, Inc. ($155.35) |
| 2020 | $92.74 | 6 | Greenwich Biosciences, Inc. ($44.77) |
| 2019 | $394.80 | 16 | JAZZ PHARMACEUTICALS INC. ($183.32) |
| 2018 | $144.32 | 14 | Sunovion Pharmaceuticals Inc. ($106.61) |
| 2017 | $6,491 | 25 | Lundbeck LLC ($6,271) |
All Payment Transactions
251 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | UCB, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,420.00 | General |
| 12/30/2024 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $130.00 | General |
| 12/30/2024 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $30.00 | General |
| 12/30/2024 | UCB, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.23 | General |
| 12/30/2024 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $5.37 | General |
| 12/30/2024 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $3.09 | General |
| 12/30/2024 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $2.64 | General |
| 12/17/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $98.25 | General |
| 12/02/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/21/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $9.40 | General |
| Category: Neurology | ||||||
| 11/20/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.00 | General |
| Category: NEUROLOGY | ||||||
| 11/19/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $20.88 | General |
| Category: Medical Device | ||||||
| 11/16/2024 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $228.85 | General |
| 11/16/2024 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $174.56 | General |
| 11/16/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $65.01 | General |
| 11/16/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 11/16/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 11/16/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 11/16/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $16.37 | General |
| 11/15/2024 | UCB, Inc. | — | Travel and Lodging | In-kind items and services | $187.92 | General |
| 11/15/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $133.67 | General |
| 11/14/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $14.89 | General |
| 11/12/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 350 | 464 | $209,523 | $76,394 |
| 2022 | 14 | 377 | 490 | $286,769 | $93,300 |
| 2021 | 18 | 514 | 699 | $355,747 | $121,065 |
| 2020 | 15 | 380 | 500 | $205,355 | $61,755 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95715 | Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring | Office | 2023 | 14 | 31 | $60,646 | $25,291 | 41.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 181 | $39,716 | $15,403 | 38.8% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 28 | 44 | $18,612 | $7,559 | 40.6% |
| 95713 | Measurement of brain wave activity with video (veeg), 2-12 hours with continuous monitoring | Office | 2023 | 13 | 13 | $32,148 | $6,626 | 20.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 41 | $17,828 | $5,658 | 31.7% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 26 | 27 | $13,352 | $5,446 | 40.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 23 | 23 | $8,090 | $2,949 | 36.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 36 | $3,680 | $2,444 | 66.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 22 | $5,025 | $2,358 | 46.9% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Office | 2023 | 13 | 13 | $5,821 | $1,505 | 25.9% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Facility | 2023 | 33 | 33 | $4,605 | $1,156 | 25.1% |
| 95715 | Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring | Office | 2022 | 19 | 38 | $76,000 | $31,097 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 135 | $36,700 | $12,985 | 35.4% |
| 95713 | Measurement of brain wave activity with video (veeg), 2-12 hours with continuous monitoring | Office | 2022 | 18 | 18 | $45,000 | $9,153 | 20.3% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2022 | 36 | 37 | $18,500 | $7,404 | 40.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 34 | 34 | $18,220 | $5,612 | 30.8% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 20 | 29 | $20,445 | $5,211 | 25.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 28 | 33 | $11,875 | $4,761 | 40.1% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 28 | 48 | $7,440 | $4,525 | 60.8% |
| 95722 | Measurement of brain wave activity with video (veeg), 37-60 hours with review and report by health care professional | Office | 2022 | 19 | 19 | $16,359 | $4,232 | 25.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 13 | 13 | $16,380 | $2,523 | 15.4% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Office | 2022 | 18 | 18 | $8,100 | $2,126 | 26.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 31 | $6,310 | $1,683 | 26.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 17 | 26 | $3,900 | $1,590 | 40.8% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Facility | 2022 | 11 | 11 | $1,540 | $397.23 | 25.8% |
About Dr. Georges Ghacibeh, M.D
Dr. Georges Ghacibeh, M.D is a Epilepsy healthcare provider based in Hackensack, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851331680.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Georges Ghacibeh, M.D has received a total of $15,551 in payments from pharmaceutical and medical device companies, with $6,638 received in 2024. These payments were reported across 251 transactions from 32 companies. The most common payment nature is "Honoraria" ($5,038).
As a Medicare-enrolled provider, Ghacibeh has provided services to 1,621 Medicare beneficiaries, totaling 2,153 services with total Medicare billing of $352,514. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Epilepsy
- Other Specialties Neurology, Clinical Neurophysiology
- Location Hackensack, NJ
- Active Since 06/08/2006
- Last Updated 12/15/2022
- Taxonomy Code 2084E0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851331680
Products in Payments
- ONFI (Drug) $6,271
- LUMRYZ (Drug) $606.23
- Briviact (Drug) $374.78
- APTIOM (Drug) $282.44
- Epidiolex (Drug) $214.51
- SUNOSI (Drug) $183.32
- EPIDIOLEX (Drug) $164.98
- KESIMPTA (Drug) $156.17
- UBRELVY (Drug) $117.56
- NURTEC ODT (Drug) $111.11
- XCOPRI (Drug) $109.67
- ACTIVA (Device) $92.02
- WAKIX (Drug) $67.78
- XYWAV (Drug) $65.01
- VYEPTI (Biological) $64.00
- RNS Neurostimulator Kit (Device) $48.13
- QULIPTA (Drug) $44.84
- VNS Therapy (Device) $37.71
- REXULTI (Drug) $32.70
- EMGALITY (Drug) $29.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.